The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded warning labels with more information about the risk of a rare heart condition after vaccination.

Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine candidate after discussions with the U.S. Food and Drug Administration. The company said it would resubmit the application later this year with vaccine efficacy data from a late-stage trial of its experimental seasonal influenza vaccine,

Since 2023, federal health officials have recommended an annual COVID-19 shot for most people, and vaccine makers have not needed to conduct additional tests on each year’s updated vaccine. It's similar to the way the annual flu shot is updated to target the newest influenza strains,

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) has officially approved a COVID-19 vaccine from Novavax for adults 65 and older and for individuals ages 12 to 64 who have an underlying health condition that puts them at higher risk for serious illness from a coronavirus infection.

The Trump administration shared the outlines of how it plans to push drug companies to lower their prices in the U.S.

The announcement, which followed the FDA setting new guidelines on COVID vaccine approvals, erased the stock’s gains from yesterday.

The stock might be down substantially over the past three years, but it isn't out of the picture yet. Teladoc Health is a telemedicine specialist that rose in popularity in 2020 and 2021, when people were stuck at home and forced to turn to telehealth for medical attention.

As of April 26, about 14% of pregnant women and 13% of children had received the updated COVID vaccine, according to the CDC. In the U.S., three COVID shots have been authorized for use - Moderna and Pfizer-BioNTech's/ messenger RNA based vaccines along with Novavax's protein-based shot.